PDCD1 and small cell lung carcinoma: This was in agreement with the aggressiveness of the clinical phenotypes and prevalent expression pattern of topoisomerase, tubulinβ-III, VEGF, VEGFR3 and PD-1 in SCLC were previously documented at histopathological or cellular levels33–37.